(Q34778364)

English

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Iqbal S Grewal

1 reference

Europe PubMed Central

4 August 2017

author name string

Ezogelin Oflazoglu

1

1 reference

Europe PubMed Central

4 August 2017

Kim M Kissler

2

1 reference

Europe PubMed Central

4 August 2017

Eric L Sievers

3

1 reference

Europe PubMed Central

4 August 2017

Hans-Peter Gerber

5

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

8 May 2008

1 reference

Europe PubMed Central

4 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

4 August 2017

142

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

69-73

1 reference

Europe PubMed Central

4 August 2017

Salvage therapy in Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

7 July 2018

Current treatment and immunotherapy of Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

7 July 2018

Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

7 July 2018

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

7 July 2018

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

7 July 2018

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07146.X

21 January 2018

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07146.X

21 January 2018

Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2440525

26 October 2018

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18477046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18477046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SGN-30 (Seattle genetics)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18477046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18477046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2008.07146.X

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34778364&oldid=1956486991"